Diseases and Disorders
- CA-125 cancer antigen
- CA 19-9 cancer antigen
- Cabazitaxel, for prostate cancer
- Cabergoline (Dostinex), for pituitary tumor
- CAGE questionnaire, in alcoholism screening
- Calcimimetics, for hyperparathyroidism
- Calcium acetate, for hypoparathyroidism
- Calcium carbonate, for hypoparathyroidism
- Calcium chloride, for hypoparathyroidism
- Calcium citrate, for hypoparathyroidism
- Calcium lactate, for hypoparathyroidism
- Calcium leucovorin, for bone cancer
- Calcium metabolism modifiers, for osteoarthritis
- Calculi, renal
- Campylobacter enteritis
- Campylobacter jejuni, Guillain-Barré syndrome and
- Canadian Cardiovascular Society grading scale
- Cancer antigen 125 (CA-125), in ovarian cancer
- Capsaicin (Zostrix), for herpes zoster
- Carbachol, for glaucoma
- Carbamazepine, for epilepsy
- Carbamazepine (Tegretol), for epilepsy
- Carbidopa levodopa (Sinemet), for Parkinson disease
- Carbohydrate deficient transferrin (CDT), in acute alcohol intoxication
- Carboprost, for postpartum hemorrhage
- Carboxyhemoglobin levels, in burns
- Cardiac contusion
- Cardiac magnetic resonance imaging (cMRI), in heart failure
- Cardiac output (CO), inadequate, in heart failure
- Cardiac standstill
- Cardiac syndrome X (microvascular angina)
- Cardiogenic shock
- Cardiomyopathy
- Cardiopulmonary resuscitation (CPR)
- Carditis, from rheumatic fever
- Carmustine, for melanoma
- Carotid artery, internal, stroke from, signs and symptoms of
- Carpal tunnel syndrome (CTS)
- Carteolol, for glaucoma
- Casirivimab-imdevimab, for COVID-19
- Caspofungin, for candidiasis
- Cation exchange resin, for chronic kidney disease
- Cefdinir, for tonsillitis
- Celecoxib, for rheumatoid arthritis
- Celiac disease (CD)
- Central cord syndrome
- Centrally acting adrenergic agents, for hypertension
- Central nervous system agent, for amyotrophic lateral sclerosis
- Centriacinar or centrilobular emphysema
- Cephalopelvic disproportion (CPD)
- Cephamycin, for gunshot wound
- cerebral
- Cerebral concussion
- Cerebral vasospasm, in subarachnoid hemorrhage
- cervical
- Cervical cancer
- Cervical insufficiency
- Cervidil (Prepidil gel), for intrauterine fetal demise
- Cervix in preterm labor, length of
- Chagas disease, myocarditis and
- Chancre, in syphilis
- Charcoal, activated, for psychoactive substance abuse
- Cheiloplasty, for cleft lip
- Chemical burns
- Chemical paralysis, for subdural hematoma
- Chemodestructive agents, for human papillomavirus
- Chikungunya virus
- Chlamydia trachomatis infections
- Chlordiazepoxide, for psychoactive substance abuse
- Chlorpropamide (Diabinese), for diabetes insipidus
- Cholangiopancreatography, endoscopic retrograde, in pancreatitis
- Cholecystitis
- Cholelithiasis
- Cholesterol synthesis inhibitors, for coronary heart disease
- Cholestyramine, for coronary heart disease
- Cholinesterase inhibitor, for Alzheimer disease
- Chondrosarcoma
- Chordoma
- Chorea, in rheumatic fever
- Chorioamnionitis
- Chronic exertional angina
- Chronic fatigue syndrome (CFS)
- Chronic leukemia
- Chronic lymphocytic leukemia (CLL)
- Chronic myelogenous leukemia (CML)
- Chronic necrotizing infection
- Chronic renal failure
- Ciclesonide, for asthma
- Cilastatin, for pancreatitis
- Cinacalcet (Sensipar), for hyperparathyroidism
- Circulatory overload, from transfusion
- Cirrhosis
- Cisatracurium (Nimbex), for ARDS
- CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised)
- Cladribine, for acute leukemia
- Claudication, intermittent, in arterial occlusive disease
- Cleft lip (CL) and cleft palate (CP)
- Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar)
- Clodronate, for multiple myeloma
- Clonazepam, for epilepsy
- Clorazepate, for psychoactive substance abuse
- Closed chest compression (CPR)
- Clostridium botulinum infection
- Clostridium difficile infection (CDI)
- Clostridium perfringens
- Clostridium tetani infection
- Cloxacillin, for osteomyelitis
- Clozapine, for Alzheimer disease
- Coagulation profile, in celiac disease
- Coagulation studies of, in hemophilia
- Cobalamin level, in pernicious anemia
- Cocaine, signs and symptoms of withdrawal
- Colestipol, for hyperlipoproteinemia
- Colon, spastic
- Colony-stimulating factors (CSFs), for aplastic anemia
- Colorectal cancer
- Colostomy
- Colporrhaphy, for pelvic organ prolapse
- Coma, in diffuse axonal injury
- Compartment syndrome, complicating musculoskeletal trauma
- Competitive inhibitors of ACE, for aortic valve insufficiency
- Complete abortion
- Computed enterography, in Crohn disease
- Concussion, cerebral
- Conivaptan, for SIADH
- Consumptive coagulopathy
- Contact burns
- Continuous hemofiltration, for chronic kidney disease
- ConvaTac, for pressure injury
- Coronary heart disease (CHD)
- Coronary vasodilators, for mitral stenosis
- Cor pulmonale
- Corpus callosotomy, for epilepsy
- Cotrimoxazole (Bactrim, Septra), for cystitis
- COVID-19 mRNA vaccine
- CPR
- Creatine clearance, in chronic kidney disease
- Creatine kinase (CK), in muscular dystrophy
- Creatinine
- Crescendo (unstable) angina
- Crescentic nephritis
- Cretinism
- Creutzfeldt-Jakob disease
- Cricopharyngeal myotomy, for esophageal diverticula
- Crohn disease (CD)
- Cromolyn sodium, for asthma
- Croup
- Cryoprecipitate, for hemophilia
- Cryotherapy, for retinal detachment
- Cryptorchidism, testicular cancer and
- Crystalline suspension of human insulin with protamine and zinc, for diabetes mellitus
- Crystalloid IV fluids, for appendicitis
- Cushing syndrome (CS)
- Cyanocobalamin, for pernicious anemia
- Cyclic polypeptide, for aplastic anemia
- Cyclobenzaprine hydrochloride (Flexeril), for herniated disk
- Cyclopentolate hydrochloride (Cyclogyl), for retinal detachment
- Cyclophilin inhibitor, for aplastic anemia
- Cyclophosphamide-vincristine-prednisone (CVP), for chronic leukemia
- Cycloplegic agent, for retinal detachment
- Cystectomy, for bladder cancer
- Cystic fibrosis (CF)
- Cystic fibrosis gene (CFTR)
- Cystography, in pelvic fractures
- Cystometry, in neurogenic bladder
- Cystoscopy, in bladder cancer
- Cytomegalovirus (CMV) infection
- Cytotoxic agents, for human papillomavirus